| |
Presentation |
Webcast |
|
December 9, 2021
Presentation by CEO Peter Zerhouni at HC Andersen Capital's Virtual Growth Days Seminar
|
|
|
|
November 29, 2021
Interview with CEO Peter Zerhouni about the enrollment of the first patient in the phase III study CONCLUDE and the way forward
|
|
|
|
November 25, 2021
Presentation with CEO Peter Zerhouni at Erik Penser Banks Bolagsdag 2021
|
|
|
|
November 24, 2021
Presentation with CEO Peter Zerhouni and CMO Thomas Knittel on the highlights of the Q3 report and a deep dive into previous clinical studies with cobitolimod
|
|
|
|
November 11, 2021
Presentation at Redeye Life Science Day 2021
|
|
|
|
October 27, 2021
Company introduction at HC Andersen Capital's online event
|
|
|
|
October 7, 2021
Presentation at HC Andersen Capital Small & Mid cap seminar
|
|
|
|
September 2, 2021
Presentation at Pareto Securities’ Healthcare Conference 2021
|
|
|
|
August 27, 2021
Redeye interviews CEO Peter Zerhouni after the release of the Q2 report
|
|
|
|
June 15, 2021
Interview with CEO Peter Zerhouni about the phase III study CONCLUDE
|
|
|
|
June 2, 2021
Presentation at Redeye Growth Day
|
|
|
|
May 6, 2021
Presentation at Erik Penser Bank's theme day - commercialization of medicines
|
|
|
|
March 11, 2021
Presentation at Barclays Global Healthcare Conference
|
|
|
|
January 28, 2021
Redeye interviews CEO Peter Zerhouni about the latest events in the company and the plans for 2021
|
|
|
|
January 7, 2021
Interview with InDex CEO Peter Zerhouni about the eventful year 2020 and what awaits in 2021
|
|
|
SVE
ENG
